Biphasic cuirass ventilation in the escalation of non-invasive ventilation in COVID-19: Case report and review
Abstract
Ventilatory alternatives to prolong noninvasive ventilation in COVID-19 patients are attractive and poorly understood. New devices to deliver negative noninvasive ventilation as biphasic cuirass ventilation (BCV) have been introduced. BCV device assist in spontaneous breathing and support ventilation. We describe a case of the combination of BCV with high-flow nasal oxygenation (HFNO) in the treatment of a COVID-19 pneumonia patient that required prolonged NIV leading to face mask intolerance, ventilator dependency secondary to residual lung fibrosis and respiratory muscular weakness. BCV provides an efficient non-invasive approach in de-escalation of therapy and weaning of prolonged NIV.
References
- Bauer AR. Mechanical respirator for newborn infants and other patients: preliminary report. JAMA 1956;161:723-5. DOI: https://doi.org/10.1001/jama.1956.62970080003016a
- Linton DM. Cuirass ventilation: a review and update. Crit Care Resusc 2005;7:22-8.
- Onweni C, Rashid S, Goswami R, et al. Cuirass ventilation: An alternative home-based modality for chronic respiratory failure. Home Health Care Manag Pract 2020;32:40-4. DOI: https://doi.org/10.1177/1084822319875111
- Takeda S, Nakanishi K, Takano T, et al. The combination of external high-frequency oscillation and pressure support ventilation in acute respiratory failure. Acta Anaesthesiol Scand 1997;41:670-4. DOI: https://doi.org/10.1111/j.1399-6576.1997.tb04765.x
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.